Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 18 | 2024 | 1263 | 3.850 |
Why?
|
Hypertrophy | 11 | 2023 | 562 | 3.840 |
Why?
|
Breast | 18 | 2023 | 1976 | 3.540 |
Why?
|
Gynecomastia | 5 | 2022 | 88 | 2.270 |
Why?
|
Acrocephalosyndactylia | 4 | 2022 | 93 | 1.930 |
Why?
|
Self Concept | 6 | 2023 | 1046 | 1.590 |
Why?
|
Surgical Flaps | 8 | 2021 | 1682 | 1.420 |
Why?
|
Thumb | 5 | 2022 | 232 | 1.310 |
Why?
|
Finger Phalanges | 3 | 2022 | 41 | 1.190 |
Why?
|
Hand Deformities | 2 | 2021 | 16 | 1.110 |
Why?
|
Body Image | 3 | 2017 | 646 | 1.070 |
Why?
|
Quality of Life | 10 | 2023 | 13510 | 1.060 |
Why?
|
Fingers | 3 | 2021 | 512 | 1.020 |
Why?
|
Jejunum | 4 | 2021 | 475 | 0.960 |
Why?
|
Ketorolac | 2 | 2024 | 95 | 0.810 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2022 | 118 | 0.760 |
Why?
|
Esophageal Atresia | 3 | 2019 | 226 | 0.750 |
Why?
|
Osteotomy | 3 | 2018 | 838 | 0.740 |
Why?
|
Fractures, Closed | 1 | 2021 | 88 | 0.710 |
Why?
|
Progestins | 1 | 2022 | 302 | 0.700 |
Why?
|
Osteogenesis, Distraction | 1 | 2022 | 238 | 0.650 |
Why?
|
Caustics | 1 | 2019 | 33 | 0.650 |
Why?
|
Fibroadenoma | 2 | 2018 | 42 | 0.640 |
Why?
|
Child | 44 | 2023 | 80960 | 0.620 |
Why?
|
Burns, Chemical | 1 | 2019 | 123 | 0.600 |
Why?
|
Adolescent | 40 | 2023 | 89244 | 0.600 |
Why?
|
Mandible | 4 | 2023 | 759 | 0.590 |
Why?
|
Glutamate-Ammonia Ligase | 5 | 2001 | 76 | 0.580 |
Why?
|
Esophagus | 2 | 2021 | 1043 | 0.540 |
Why?
|
Young Adult | 31 | 2023 | 60131 | 0.540 |
Why?
|
Orbital Fractures | 1 | 2017 | 109 | 0.530 |
Why?
|
Pressure Ulcer | 1 | 2018 | 159 | 0.530 |
Why?
|
Foot Deformities, Congenital | 1 | 2016 | 59 | 0.520 |
Why?
|
Upper Extremity Deformities, Congenital | 1 | 2016 | 32 | 0.510 |
Why?
|
Hand Deformities, Congenital | 2 | 2014 | 175 | 0.510 |
Why?
|
Hematoma | 2 | 2024 | 768 | 0.480 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 420 | 0.480 |
Why?
|
Overweight | 3 | 2022 | 2448 | 0.470 |
Why?
|
Nausea | 1 | 2017 | 682 | 0.470 |
Why?
|
Patient Satisfaction | 5 | 2019 | 3492 | 0.460 |
Why?
|
Glutamine | 5 | 2001 | 578 | 0.460 |
Why?
|
Syndactyly | 1 | 2014 | 75 | 0.460 |
Why?
|
Vomiting | 1 | 2017 | 655 | 0.460 |
Why?
|
Microsurgery | 3 | 2016 | 803 | 0.460 |
Why?
|
Abnormalities, Multiple | 3 | 2016 | 1423 | 0.430 |
Why?
|
Finger Injuries | 3 | 2016 | 145 | 0.430 |
Why?
|
Limb Deformities, Congenital | 2 | 2021 | 136 | 0.420 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 260 | 0.420 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 213 | 0.420 |
Why?
|
Computer-Assisted Instruction | 1 | 2016 | 366 | 0.410 |
Why?
|
Retinitis Pigmentosa | 1 | 2016 | 395 | 0.410 |
Why?
|
Mental Health | 3 | 2017 | 3275 | 0.400 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2011 | 67 | 0.360 |
Why?
|
Epoxy Compounds | 1 | 2011 | 137 | 0.360 |
Why?
|
Obesity | 6 | 2022 | 13091 | 0.360 |
Why?
|
Retrospective Studies | 29 | 2024 | 81903 | 0.350 |
Why?
|
Scalp | 3 | 2013 | 391 | 0.350 |
Why?
|
Mutagens | 1 | 2011 | 181 | 0.350 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1279 | 0.340 |
Why?
|
Long QT Syndrome | 1 | 2014 | 472 | 0.340 |
Why?
|
Hand | 4 | 2022 | 913 | 0.340 |
Why?
|
Female | 52 | 2024 | 397515 | 0.330 |
Why?
|
Polydactyly | 2 | 2021 | 57 | 0.330 |
Why?
|
Fractures, Bone | 2 | 2021 | 2063 | 0.330 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 2009 | 40 | 0.320 |
Why?
|
Postoperative Period | 3 | 2020 | 1830 | 0.320 |
Why?
|
Humans | 76 | 2024 | 768970 | 0.320 |
Why?
|
Pain, Postoperative | 2 | 2018 | 1767 | 0.320 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2276 | 0.310 |
Why?
|
Treatment Outcome | 18 | 2021 | 65480 | 0.310 |
Why?
|
Fanconi Anemia | 1 | 2011 | 327 | 0.310 |
Why?
|
Lipomatosis | 1 | 2009 | 112 | 0.300 |
Why?
|
Mandibular Neoplasms | 2 | 2023 | 131 | 0.300 |
Why?
|
Child, Preschool | 20 | 2023 | 42683 | 0.290 |
Why?
|
Fibroma | 1 | 2009 | 199 | 0.290 |
Why?
|
Hemangioma | 2 | 2023 | 727 | 0.290 |
Why?
|
Nevus | 1 | 2009 | 205 | 0.290 |
Why?
|
Genetic Counseling | 1 | 2011 | 634 | 0.280 |
Why?
|
Homocystinuria | 1 | 2007 | 65 | 0.280 |
Why?
|
Hand Deformities, Acquired | 1 | 2006 | 36 | 0.270 |
Why?
|
Body Mass Index | 5 | 2018 | 13055 | 0.270 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2001 | 1169 | 0.250 |
Why?
|
Postoperative Complications | 7 | 2024 | 15889 | 0.240 |
Why?
|
Autistic Disorder | 1 | 2014 | 1240 | 0.240 |
Why?
|
Follow-Up Studies | 12 | 2018 | 39394 | 0.240 |
Why?
|
Fractures, Ununited | 1 | 2006 | 176 | 0.240 |
Why?
|
Referral and Consultation | 3 | 2021 | 3628 | 0.240 |
Why?
|
Mastectomy | 3 | 2024 | 1850 | 0.230 |
Why?
|
Surgery, Oral | 2 | 2017 | 133 | 0.230 |
Why?
|
Carcinoma, Basal Cell | 1 | 2009 | 565 | 0.220 |
Why?
|
Infant | 14 | 2023 | 36556 | 0.220 |
Why?
|
Weight Loss | 1 | 2015 | 2721 | 0.220 |
Why?
|
Vascular Malformations | 1 | 2009 | 469 | 0.220 |
Why?
|
Male | 39 | 2023 | 365203 | 0.220 |
Why?
|
Up-Regulation | 1 | 2012 | 4148 | 0.210 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2023 | 103 | 0.210 |
Why?
|
Methionine Sulfoximine | 2 | 1999 | 12 | 0.200 |
Why?
|
Skin Neoplasms | 3 | 2011 | 5864 | 0.200 |
Why?
|
Curriculum | 1 | 2016 | 3782 | 0.200 |
Why?
|
Computer Simulation | 1 | 2016 | 6291 | 0.200 |
Why?
|
Prospective Studies | 7 | 2023 | 54962 | 0.200 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2021 | 36 | 0.190 |
Why?
|
Glutaminase | 1 | 2001 | 32 | 0.190 |
Why?
|
Soft Tissue Neoplasms | 2 | 2009 | 1166 | 0.190 |
Why?
|
Electrocardiography | 1 | 2014 | 6413 | 0.190 |
Why?
|
Toes | 3 | 2021 | 209 | 0.190 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 131 | 0.180 |
Why?
|
Facial Injuries | 1 | 2022 | 191 | 0.180 |
Why?
|
Breast Neoplasms, Male | 1 | 2022 | 212 | 0.170 |
Why?
|
Esophageal Diseases | 1 | 2021 | 168 | 0.170 |
Why?
|
Health Surveys | 3 | 2015 | 4055 | 0.170 |
Why?
|
Incidental Findings | 2 | 2022 | 697 | 0.160 |
Why?
|
Carrier Proteins | 1 | 2012 | 4939 | 0.160 |
Why?
|
Breast Neoplasms | 5 | 2021 | 21188 | 0.160 |
Why?
|
Free Tissue Flaps | 1 | 2023 | 337 | 0.150 |
Why?
|
Ankylosis | 1 | 2018 | 39 | 0.150 |
Why?
|
Longitudinal Studies | 3 | 2020 | 14794 | 0.150 |
Why?
|
Goldenhar Syndrome | 1 | 2018 | 40 | 0.150 |
Why?
|
Fibula | 2 | 2018 | 270 | 0.140 |
Why?
|
Cytokines | 1 | 2012 | 7453 | 0.140 |
Why?
|
Recurrence | 2 | 2020 | 8513 | 0.140 |
Why?
|
Linear Models | 2 | 2018 | 5891 | 0.140 |
Why?
|
Radiography | 3 | 2014 | 6991 | 0.130 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9549 | 0.130 |
Why?
|
Oral Surgical Procedures | 1 | 2018 | 172 | 0.130 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26395 | 0.130 |
Why?
|
Diplopia | 1 | 2017 | 217 | 0.130 |
Why?
|
Esophagoplasty | 1 | 2015 | 48 | 0.130 |
Why?
|
Internship and Residency | 1 | 2016 | 5956 | 0.130 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 704 | 0.130 |
Why?
|
Transsexualism | 1 | 2019 | 210 | 0.120 |
Why?
|
Estrogens | 1 | 2022 | 1536 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2022 | 22296 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1216 | 0.120 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2018 | 227 | 0.120 |
Why?
|
Treatment Refusal | 1 | 2018 | 433 | 0.120 |
Why?
|
Surgery, Plastic | 2 | 2022 | 651 | 0.120 |
Why?
|
Appointments and Schedules | 1 | 2018 | 443 | 0.110 |
Why?
|
Synostosis | 1 | 2014 | 45 | 0.110 |
Why?
|
Graft Rejection | 1 | 2007 | 4492 | 0.110 |
Why?
|
Upper Extremity | 1 | 2019 | 683 | 0.110 |
Why?
|
Salvage Therapy | 2 | 2018 | 1277 | 0.110 |
Why?
|
Craniofacial Abnormalities | 1 | 2016 | 320 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2018 | 1183 | 0.110 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2013 | 25 | 0.110 |
Why?
|
Esthetics | 1 | 2015 | 330 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 13021 | 0.110 |
Why?
|
Preoperative Period | 1 | 2015 | 565 | 0.110 |
Why?
|
Melanoma | 1 | 2011 | 5709 | 0.110 |
Why?
|
Adult | 14 | 2023 | 223851 | 0.110 |
Why?
|
RNA Splice Sites | 1 | 2014 | 213 | 0.110 |
Why?
|
Cohort Studies | 5 | 2020 | 41808 | 0.100 |
Why?
|
Phenotype | 4 | 2016 | 16731 | 0.100 |
Why?
|
Hypospadias | 1 | 2013 | 98 | 0.100 |
Why?
|
Ectodermal Dysplasia | 1 | 2013 | 107 | 0.100 |
Why?
|
Postoperative Care | 1 | 2018 | 1481 | 0.100 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 771 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2252 | 0.100 |
Why?
|
Nipples | 2 | 2013 | 229 | 0.100 |
Why?
|
Amputation, Traumatic | 2 | 2016 | 135 | 0.100 |
Why?
|
Muscle Hypotonia | 1 | 2013 | 166 | 0.100 |
Why?
|
Cafe-au-Lait Spots | 1 | 2011 | 20 | 0.090 |
Why?
|
Bone Transplantation | 2 | 2023 | 925 | 0.090 |
Why?
|
Risk Factors | 8 | 2024 | 74976 | 0.090 |
Why?
|
Arm Injuries | 1 | 2012 | 156 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 1999 | 1966 | 0.090 |
Why?
|
Leg Injuries | 1 | 2012 | 180 | 0.090 |
Why?
|
Anastomosis, Surgical | 2 | 2021 | 994 | 0.090 |
Why?
|
Compartment Syndromes | 1 | 2012 | 159 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4862 | 0.090 |
Why?
|
Nails | 2 | 2016 | 298 | 0.090 |
Why?
|
Infant, Newborn | 6 | 2023 | 26428 | 0.090 |
Why?
|
Alkaline Phosphatase | 1 | 1993 | 864 | 0.090 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2009 | 56 | 0.080 |
Why?
|
Syndrome | 1 | 2016 | 3274 | 0.080 |
Why?
|
Pseudarthrosis | 1 | 2009 | 54 | 0.080 |
Why?
|
Length of Stay | 3 | 2018 | 6526 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3773 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2018 | 9442 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4265 | 0.080 |
Why?
|
Facial Neoplasms | 1 | 2009 | 126 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 1999 | 7609 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15471 | 0.070 |
Why?
|
Injury Severity Score | 2 | 2012 | 1049 | 0.070 |
Why?
|
Dexamethasone | 3 | 2001 | 1965 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1672 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2019 | 1946 | 0.070 |
Why?
|
Critical Illness | 1 | 2000 | 2754 | 0.070 |
Why?
|
Faculty, Medical | 1 | 2016 | 1226 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4356 | 0.070 |
Why?
|
Skin Transplantation | 1 | 2012 | 1097 | 0.070 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2011 | 737 | 0.070 |
Why?
|
Hamartoma | 1 | 2009 | 236 | 0.070 |
Why?
|
Craniosynostoses | 1 | 2011 | 416 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2518 | 0.070 |
Why?
|
Publishing | 1 | 2014 | 837 | 0.070 |
Why?
|
Clavicle | 1 | 2009 | 224 | 0.070 |
Why?
|
Comorbidity | 2 | 2012 | 10592 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1194 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2012 | 2360 | 0.060 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7957 | 0.060 |
Why?
|
Preoperative Care | 1 | 2014 | 2258 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 1547 | 0.060 |
Why?
|
Lung | 3 | 1998 | 10099 | 0.060 |
Why?
|
Orthopedics | 1 | 2014 | 906 | 0.060 |
Why?
|
Sarcoma | 2 | 2013 | 1806 | 0.060 |
Why?
|
Incidence | 3 | 2021 | 21547 | 0.060 |
Why?
|
Databases, Factual | 2 | 2011 | 8094 | 0.060 |
Why?
|
Mutation | 2 | 2023 | 30266 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 1999 | 4978 | 0.060 |
Why?
|
Muscles | 1 | 2009 | 1582 | 0.060 |
Why?
|
Sutures | 1 | 2006 | 283 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3438 | 0.060 |
Why?
|
Medical Records | 1 | 2009 | 1411 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2013 | 2592 | 0.050 |
Why?
|
Fracture Healing | 1 | 2006 | 448 | 0.050 |
Why?
|
Pediatrics | 1 | 2018 | 3628 | 0.050 |
Why?
|
RNA, Messenger | 5 | 2001 | 12806 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2014 | 3205 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3838 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3928 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2013 | 2986 | 0.050 |
Why?
|
Risk Assessment | 3 | 2014 | 24333 | 0.050 |
Why?
|
Wound Healing | 1 | 2012 | 2815 | 0.050 |
Why?
|
Pyridines | 1 | 1993 | 2895 | 0.050 |
Why?
|
Rats | 5 | 2001 | 23786 | 0.050 |
Why?
|
Lower Extremity | 1 | 2009 | 1217 | 0.050 |
Why?
|
Cicatrix | 1 | 2006 | 799 | 0.040 |
Why?
|
Clinical Competence | 1 | 2016 | 4860 | 0.040 |
Why?
|
Fracture Fixation, Internal | 1 | 2006 | 982 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 13048 | 0.040 |
Why?
|
Glucocorticoids | 2 | 1999 | 2167 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 1999 | 8144 | 0.040 |
Why?
|
Connective Tissue Cells | 1 | 2018 | 50 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2590 | 0.040 |
Why?
|
Nutritional Support | 1 | 2000 | 178 | 0.040 |
Why?
|
Adenoma | 1 | 2009 | 2163 | 0.040 |
Why?
|
Exercise | 1 | 2015 | 5954 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2001 | 665 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2018 | 510 | 0.040 |
Why?
|
Enzyme Stability | 1 | 1998 | 219 | 0.040 |
Why?
|
Reoperation | 2 | 2021 | 4342 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2009 | 8559 | 0.040 |
Why?
|
Maxillofacial Development | 1 | 2018 | 88 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4879 | 0.040 |
Why?
|
Skin | 1 | 2011 | 4506 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1154 | 0.040 |
Why?
|
Muscle Neoplasms | 1 | 1998 | 130 | 0.040 |
Why?
|
Fibrosarcoma | 1 | 1998 | 313 | 0.030 |
Why?
|
Endotoxemia | 1 | 1997 | 198 | 0.030 |
Why?
|
Societies, Medical | 2 | 2022 | 3968 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7478 | 0.030 |
Why?
|
Dental Staff | 1 | 2015 | 14 | 0.030 |
Why?
|
Time Management | 1 | 2015 | 53 | 0.030 |
Why?
|
Adrenalectomy | 1 | 1997 | 348 | 0.030 |
Why?
|
Practice Management | 1 | 2015 | 37 | 0.030 |
Why?
|
Sepsis | 2 | 2000 | 2610 | 0.030 |
Why?
|
Lacerations | 1 | 2016 | 150 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2018 | 1342 | 0.030 |
Why?
|
Feedback | 1 | 1998 | 799 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2009 | 2931 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2000 | 2226 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2094 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20776 | 0.030 |
Why?
|
Financial Management | 1 | 2015 | 161 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2009 | 4064 | 0.030 |
Why?
|
Schools | 1 | 2022 | 1498 | 0.030 |
Why?
|
Gender Identity | 1 | 2019 | 770 | 0.030 |
Why?
|
Salaries and Fringe Benefits | 1 | 2015 | 262 | 0.030 |
Why?
|
Age Factors | 2 | 2021 | 18435 | 0.030 |
Why?
|
Group Processes | 1 | 2014 | 228 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2013 | 190 | 0.030 |
Why?
|
Hydrolysis | 1 | 1993 | 646 | 0.030 |
Why?
|
Ear, External | 1 | 2013 | 165 | 0.030 |
Why?
|
Electrons | 1 | 1993 | 264 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1313 | 0.020 |
Why?
|
United States | 4 | 2022 | 73186 | 0.020 |
Why?
|
Catalysis | 1 | 1993 | 768 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2019 | 1839 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2280 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2875 | 0.020 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2012 | 156 | 0.020 |
Why?
|
Workflow | 1 | 2015 | 859 | 0.020 |
Why?
|
Bibliometrics | 1 | 2014 | 355 | 0.020 |
Why?
|
Homeostasis | 1 | 2001 | 3347 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2022 | 3709 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1669 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2434 | 0.020 |
Why?
|
Middle Aged | 5 | 2018 | 223737 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2000 | 2905 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2664 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2013 | 2749 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3726 | 0.020 |
Why?
|
Extremities | 1 | 1994 | 870 | 0.020 |
Why?
|
Protons | 1 | 1993 | 1113 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2000 | 2517 | 0.020 |
Why?
|
Suture Techniques | 1 | 2012 | 779 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12095 | 0.020 |
Why?
|
Cell Line | 1 | 2001 | 15604 | 0.020 |
Why?
|
Tattooing | 1 | 2007 | 57 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3931 | 0.020 |
Why?
|
Osteolysis | 1 | 2009 | 274 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1876 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3952 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3775 | 0.020 |
Why?
|
Animals | 5 | 2001 | 169335 | 0.020 |
Why?
|
Pedigree | 1 | 2013 | 4545 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2009 | 59739 | 0.020 |
Why?
|
Boston | 1 | 2016 | 9377 | 0.010 |
Why?
|
Necrosis | 1 | 2007 | 1620 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19023 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10486 | 0.010 |
Why?
|
Phosphorylation | 1 | 1993 | 8317 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8749 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36854 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13427 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11684 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17629 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10868 | 0.010 |
Why?
|
Lipopolysaccharides | 2 | 1998 | 2222 | 0.010 |
Why?
|
Physicians | 1 | 2017 | 4607 | 0.010 |
Why?
|
Ischemia | 1 | 2007 | 1900 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40261 | 0.010 |
Why?
|
Aged | 2 | 2009 | 171786 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1997 | 455 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1998 | 825 | 0.010 |
Why?
|
Cachexia | 1 | 1998 | 202 | 0.010 |
Why?
|
Endotoxins | 1 | 1997 | 520 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7460 | 0.010 |
Why?
|
Prevalence | 1 | 2009 | 15879 | 0.010 |
Why?
|
Neutropenia | 1 | 1997 | 893 | 0.010 |
Why?
|
Blotting, Western | 1 | 1998 | 5033 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1997 | 10765 | 0.000 |
Why?
|
Escherichia coli | 1 | 1997 | 4213 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1998 | 8664 | 0.000 |
Why?
|
Survival Rate | 1 | 1994 | 12873 | 0.000 |
Why?
|
Prognosis | 1 | 1994 | 30046 | 0.000 |
Why?
|